EAST PROVIDENCE, RI — A Rhode Island orthopedic surgeon has performed the state’s first thumb joint replacement using a newly available implant designed to treat painful arthritis at the base of the thumb.

Dr. Joseph A. Gil, a hand and upper extremity surgeon at University Orthopedics, performed the procedure at Rhode Island Hospital using the TOUCH CMC 1 prosthesis, which received FDA approval in 2025 after more than a decade of use in Europe.
The surgery, known as carpometacarpal, or CMC, total joint arthroplasty, replaces the arthritic joint at the base of the thumb with a small ball-and-socket implant. According to Dr. Gil, the concept is similar to a hip replacement, but on a much smaller scale and designed specifically for the thumb.
Thumb arthritis can make routine activities — turning a key, buttoning a shirt, gripping a cup or opening a jar — difficult and painful. As cartilage in the CMC joint wears away, patients may experience pain, weakness and loss of grip and pinch strength.
Traditionally, surgery for advanced thumb arthritis has often involved removing the trapezium, a small bone at the base of the thumb, and reconstructing the joint using nearby tendon tissue. According to a news release from UOI, the TOUCH implant provides another approach: replacing the damaged joint with a dual-mobility prosthesis designed to provide stability while preserving thumb movement.
“Every patient is different, and there is no one-size-fits-all treatment for thumb arthritis,” Gil said. “Having access to this technology allows us to offer another evidence-based option for patients whose symptoms have not improved with conservative treatment.”
Before surgery is considered, treatment for thumb arthritis can include splinting, medication, corticosteroid injections and hand therapy.
The TOUCH CMC 1 was developed by KeriMedical and is distributed in the United States by Medartis. Its FDA approval opened the U.S. market to a technology that had previously been used overseas.









